ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Tract Infections

COVID-19 trials near Madrid, MD, ESP:

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Madrid, Spain and 123 other locations

The aim of this study is to evaluate the efficacy of dexamethasone in hospitalized adults with COVID-19 pneumonia who do not requir...

Enrolling
COVID-19
Acute Respiratory Distress Syndrome
Drug: Dexamethasone

Phase 3

Madrid Health Service

Madrid, Spain and 2 other locations

pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...

Enrolling
COVID-19
Bacterial Pneumonia
Drug: Placebo (human albumin 1%)
Drug: Trimodulin

Phase 3

Biotest

Madrid, Spain and 58 other locations

study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...

Enrolling
Covid19
Corona Virus Infection
Drug: Baricitinib

Phase 3

Lilly
Lilly

Madrid, Madrid, Comunidad De, Spain and 19 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Madrid, Spain and 214 other locations

The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need t...

Active, not recruiting
COVID-19
SARS CoV 2 Infection
Drug: Bemnifosbuvir (BEM)
Drug: Placebo

Phase 3

Atea Pharmaceuticals
Atea Pharmaceuticals

Madrid, Spain and 263 other locations

OA investigational vaccine when it is co-administered with a COVID-19 messenger ribonucleic acid (mRNA) vaccine (Omicron XBB.1.5), ...

Enrolling
Respiratory Syncytial Virus Infections
Biological: COVID-19 mRNA vaccine
Biological: RSVPreF3 OA investigational vaccine

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Madrid, Spain and 24 other locations

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Other: Placebo
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)

Phase 2, Phase 3

Novavax
Novavax

Madrid, Spain and 94 other locations

This is a Phase IIb, open-label, uncontrolled, multi-centre, non-inferiority clinical trial, to assess the safety and immunogenicity of BIMERVAX® as...

Enrolling
SARS CoV 2 Infection
Biological: BIMERVAX

Phase 2

Hipra

Madrid, Spain and 6 other locations

This is a phase IIb/III, double-blind, randomised, active-controlled, multi-centre, non-inferiority clinical trial that aims to determine safety, tol...

Active, not recruiting
SARS-CoV2 Infection
Biological: PHH-1V81
Biological: Comirnaty Omicron XBB1.5

Phase 2, Phase 3

Hipra

Madrid, Spain and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems